AXIM has filed provisional patents relating to the unique formulation of its cannabinoid-containing oral care products with the development and commercialization of oral healthcare products, “Oraximax™”, based on cannabigerol (patent pending).
These formulations will target the daily use market as well as provide remedies for use in resolution of oral care infections and gum diseases. The Company is focusing on research and development of commercial hemp-derived cannabinoid-based oral health products. It is known that certain cannabinoids act as effective anti-inflammatory, bactericidal, anti-proliferative, and regenerating agents. It is also known that the oral cavity, being continuously traumatized by chewing, speaking, and being populated with numerous infectious organisms, is in need of effective oral health products. For these reasons, AXIM has created a new category within the oral care consumer products market.
AXIM will pioneer new patent-pending formulations for the following product categories: toothpaste, dentifrice, oral rinse liquid, oral gel and dental floss.